Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lahner, Harald
NCT04579679 / 2020-006118-19: Open-Label Surufatinib in European Patients With NET	Active, not recruiting	2	78	Europe, US	Surufatinib, HMPL-012, sulfatinib	Hutchmed	Neuroendocrine Tumours, Neuroendocrine Tumour of the Lung, Small Intestinal NET	09/24	09/24